[1] NUSSE R,CLEVERS H.Wnt/β-catenin signaling,disease,and emerging therapeutic modalities[J].Cell,2017,169(6):985-999.
[2] JAMIESON C,SHARMA M,HENDERSON B.Targeting the β-catenin nuclear transport pathway in cancer[J].Semin Cancer Biol,2014,27:20-29.
[3] KIM S,XU X,HECHT A,et al.Mediator is a transducer of Wnt/beta-catenin signaling[J].J Biol Chem,2006,281(20):14066-14075.
[4] STEWART M.Molecular mechanism of the nuclear protein import cycle[J].Nat Rev Mol Cell Bio,2007,8(3):195-208.
[5] WäLDE S,THAKAR K,HUTTEN S,et al.The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner[J].Traffic,2012,13(2):218-233.
[6] HAMADA M,HAEGER A,JEGANATHAN K,et al.Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability[J].J Mol Cell Biol,2011,194(4):597-612.
[7] FAGOTTO F,GLÜCK U,GUMBINER B.Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin[J].Curr Biol,1998,8(4):181-190.
[8] MORGAN R,RIDSDALE J,TONKS A,et al.Factors affecting the nuclear localization of β-catenin in normal and malignant tissue[J].J Cell Biochem,2014,115(8):1351-1361.
[9] YUAN K,XIE K,LAN T,et al.TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin[J].Cell Death Differ,2020,27(4):1355-1368.
[10] ASALLY M,YONEDA Y.Beta-catenin can act as a nuclear import receptor for its partner transcription factor,lymphocyte enhancer factor-1 (lef-1)[J].Exp Cell Res,2005,308(2):357-363.
[11] GRIFFIN JN,DEL VISO F,DUNCAN AR,et al.RAPGEF5 regulates nuclear translocation of β-catenin[J].Dev Cell,2018,44(2):248-260.e4.
[12] WU X,TU X,JOENG K,et al.Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling[J].Cell,2008,133(2):340-353.
[13] VUONG L,IOMINI C,BALMER S,et al.Kinesin-2 and IFT-A act as a complex promoting nuclear localization of β-catenin during Wnt signalling[J].Nat Commun,2018,9(1):5304.
[14] SAYAT R,LEBER B,GRUBAC V,et al.O-GlcNAc-glycosylation of beta-catenin regulates its nuclear localization and transcriptional activity[J].Exp Cell Res,2008,314(15):2774-2787.
[15] HUTTEN S,KEHLENBACH R.CRM1-mediated nuclear export:to the pore and beyond[J].Trends Cell Biol,2007,17(4):193-201.
[16] HAO Y,LAFITA-NAVARRO M,ZACHARIAS L,et al.Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation[J].Cell Commun Signal,2019,17(1):129.
[17] WIECHENS N,FAGOTTO F.CRM1- and Ran-independent nuclear export of beta-catenin[J].Curr Biol,2001,11(1):18-27.
[18] HENDRIKSEN J,FAGOTTO F,VAN DER VELDE H,et al.RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1[J].J Cell Biol,2005,171(5):785-797.
[19] FRANKLIN-MURRAY A,MALLYA S,JANKEEL A,et al.Toxoplasma gondii dysregulates barrier function and mechanotransduction signaling in human endothelial cells[J].mSphere,2020,5(1):e00550-19.
[20] YAN W,LIN C,GUO Y,et al.N-cadherin overexpression mobilizes the protective effects of mesenchymal stromal cells against ischemic heart injury through a β-catenin-dependent manner[J].Circ Res,2020,126(7):857-874.
[21] NADANAKA S,KINOUCHI H,KITAGAWA H.Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion[J].J Bio Chem,2018,293(2):444-465.
[22] LE S,YU M,YAN J.Phosphorylation reduces the mechanical stability of the α-catenin/β-catenin complex[J].Angew Chem Int Ed Engl,2019,58(51):18663-18669.
[23] SILVA-GARCÍA O,VALDEZ-ALARCóN J,BAIZABAL-AGUIRRE V.Wnt/β-catenin signaling as a molecular target by pathogenic bacteria[J].Front Immunol,2019,10:2135.
[24] HUA K,LI Y,ZHOU H,et al.Haemophilus parasuis infection disrupts adherens junctions and initializes EMT dependent on canonical Wnt/β-catenin signaling pathway[J].Front Cell Infect Microbiol,2018,8:324.
[25] COTT C,THUENAUER R,LANDI A,et al.Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation[J].Biochim Biophys Acta 2016,1863:1106-1118.
[26] LIN S,XIA W,WANG J,et al.Beta-catenin,a novel prognostic marker for breast cancer:its roles in cyclin D1 expression and cancer progression[J].P Natl Acad SCI USA,2000,97(8):4262-4266.
[27] ZELJKO M,PECINA-SLAUS N,MARTIC T,et al.Molecular alterations of E-cadherin and beta-catenin in brain metastases[J].Front Biosci,2011,3:616-624.
[28] PRASAD C,MIRZA S,SHARMA G,et al.Epigenetic alterations of CDH1 and APC genes:relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast[J].Life Sci,2008,83:318-325.
[29] COX O,EDMUNDS S,SIMON-KELLER K,et al.PDLIM2 is a marker of adhesion and β-catenin activity in triple-negative breast cancer[J].Cancer Res,2019,79(10):2619-2633.
[30] YU Y,WANG X,ZHANG X,et al.ERK inhibition promotes neuroectodermal precursor commitment by blocking self-renewal and primitive streak formation of the epiblast[J].Stem Cell Res Ther,2018,9(1):2.
[31] ZHOU X,CHADAREVIAN J,RUIZ B,et al.Cytoplasmic and nuclear TAZ exert distinct functions in regulating primed pluripotency[J].Stem Cell Reports,2017,9(3):732-741.
[32] STEINHART Z,ANGERS S.Wnt signaling in development and tissue homeostasis[J].Development,2018,145(11):dev146589.
[33] KRIEGHOFF E,BEHRENS J,MAYR B.Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention[J].J Cell Sci,2006,119:1453-1463.
[34] AOKI K,TAKETO M.Adenomatous polyposis coli (APC):a multi-functional tumor suppressor gene[J].J Cell Sci,2007,120:3327-3335.
[35] ZHANG Y,LIU S,MICKANIN C,et al.RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling[J].Nat Cell Biol,2011,13(5):623-629.
[36] DAROSA P,WANG Z,JIANG X,et al.Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal[J].Nature,2015,517(7533):223-226.
[37] HE J,ZHANG J,DONG L,et al.Dihydromyricetin attenuates metabolic syndrome and improves insulin sensitivity by upregulating insulin receptor substrate-1 (Y612) tyrosine phosphorylation in db/db mice[J].Diabetes Metab Syndr Obes,2019,12:2237-2249.
[38] HUANG S,MISHINA Y,LIU S,et al.Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling[J].Nature,2009,461(7264):614-620.
[39] COLUCCIA A,VACCA A,DUñACH M,et al.Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation[J].Embo J,2007,26(5):1456-1466.
[40] KAJIGUCHI T,CHUNG E,LEE S,et al.FLT3 regulates beta-catenin tyrosine phosphorylation,nuclear localization,and transcriptional activity in acute myeloid leukemia cells[J].Leukemia,2007,21(12):2476-2484.
[41] KAJIGUCHI T,LEE S,LEE M,et al.KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia[J].Leukemia Res,2008,32(5):761-770.
[42] ANTHONY CC,ROBBINS DJ,AHMED Y,et al.Nuclear regulation of Wnt/β-catenin signaling:it's a complex situation[J].Genes (Basel),2020,11(8):886.
[43] MIESZCZANEK J,VAN TIENEN L,IBRAHIM A,et al.Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models[J].Nat Commun,2019,10(1):724.
[44] HENDERSON B,GALEA M,SCHUECHNER S,et al.Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin.Regulation by histone deacetylase 1[J].J Biol Chem,2002,277(27):24258-24264.
[45] MORGAN R,RIDSDALE J,PAYNE M,et al.LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells[J].Haematologica,2019,104(7):1365-1377.
[46] LU Y,XIE S,ZHANG W,et al.Twa1/Gid8 is a β-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis[J].Cell Res,2017,27(12):1422-1440.
[47] ROSENBLUH J,NIJHAWAN D,COX A,et al.β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis[J].Cell,2012,151(7):1457-1473.
[48] SHIN H,ISLAM R,YOON W,et al.Pin1-mediated modification prolongs the nuclear retention of β-catenin in Wnt3a-induced osteoblast differentiation[J].J Biol Chem,2016,291(11):5555-5565.
[49] BALDUS S,MÖNIG S,HUXEL S,et al.MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis[J].Clin Cancer Res,2004,10(8):2790-2796.
[50] ANNA C,IIDA M,SILLS R,et al.Expression of potential beta-catenin targets,cyclin D1,c-Jun,c-Myc,E-cadherin,and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice[J].Toxicol Appl Pharm,2003,190(2):135-145.
[51] WANG B,LI X,LIU L,et al.β-catenin:oncogenic role and therapeutic target in cervical cancer[J].Biol Res,2020,53(1):33.
[52] KOSUGI S,HASEBE M,ENTANI T,et al.Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling[J].Chem Biol,2008,15(9):940-949.
[53] AMBRUS G,WHITBY L,SINGER E,et al.Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport[J].Bioorgan Med Chem,2010,18(21):7611-7620.
[54] HINTERSTEINER M,AMBRUS G,BEDNENKO J,et al.Identification of a small molecule inhibitor of importin β mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries[J].ACS Chem Biol,2010,5(10):967-979.
[55] SODERHOLM J,BIRD S,KALAB P,et al.Importazole,a small molecule inhibitor of the transport receptor importin-β[J].ACS Chem Biol,2011,6(7):700-708.
[56] GASIOROWSKI J,DEAN D.Mechanisms of nuclear transport and interventions[J].Adv Drug Deliver Rev,2003,55(6):703-716.
[57] PÁLMER H,GONZáLEZ-SANCHO J,ESPADA J,et al.Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling[J].J Cell Biol,2001,154(2):369-387.
[58] NG K,MEYERHARDT J,WU K,et al.Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer[J].J Clin Oncol,2008,26(18):2984-2991.
[59] NG K,WOLPIN B,MEYERHARDT J,et al.Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer[J].Brit J Cancer,2009,101(6):916-923.
[60] NG K,SARGENT D,GOLDBERG R,et al.Vitamin D status in patients with stage Ⅳ colorectal cancer:findings from intergroup trial N9741[J].J Clin Oncol,2011,29(12):1599-1606.
[61] SHERMAN M,YU R,ENGLE D,et al.Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy[J].Cell,2014,159(1):80-93.
[62] HOPE C,PLANUTIS K,PLANUTIENE M,et al.Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells:implications for colon cancer prevention[J].Mol Nutr Food Res,2008:S52-S61.
[63] LEOW P,TIAN Q,ONG Z,et al.Antitumor activity of natural compounds,curcumin and PKF118-310,as Wnt/β-catenin antagonists against human osteosarcoma cells[J].Invest New Drug,2010,28(6):766-782.
[64] MUKHERJEE S,MAZUMDAR M,CHAKRABORTY S,et al.Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop[J].Stem Cell Res Ther,2014,5(5):116.
[65] DAUGHERTY R,GOTTARDI C.Phospho-regulation of beta-catenin adhesion and signaling functions[J].Physiology,2007,22:303-309.
[66] BREMBECK F,SCHWARZ-ROMOND T,BAKKERS J,et al.Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions[J].Gene Dev,2004,18(18):2225-2230.
[67] TAURIN S,SANDBO N,QIN Y,et al.Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase[J].J Biol Chem,2006,281(15):9971-9976.
[68] GAMMONS M,BIENZ M.Multiprotein complexes governing Wnt signal transduction[J].Curr Opin Cell Biol,2018,51:42-49.